Cargando…
MicroRNA-101 modulates cisplatin chemoresistance in liver cancer cells via the DNA-PKcs signaling pathway
Due to the high incidence of liver cancer, chemoradiotherapy and prognosis of liver cancer are a primary focus of medical research. microRNAs (miRNAs/miRs) serve crucial roles in resistance to chemotherapy and radiotherapy. The aim of the present study was to investigate the effects of miR-101 on th...
Autores principales: | Chai, Zongtao, Yin, Xiaolan, Chen, Jin, Shi, Jie, Sun, Juxian, Liu, Chang, Liu, Feng, Cheng, Shuqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733017/ https://www.ncbi.nlm.nih.gov/pubmed/31516578 http://dx.doi.org/10.3892/ol.2019.10674 |
Ejemplares similares
-
Targeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation
por: Yan, Dan, et al.
Publicado: (2010) -
MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
por: Chen, Xin, et al.
Publicado: (2019) -
All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial
por: Shi, Jie, et al.
Publicado: (2019) -
MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin
por: Yin, Zhaojun, et al.
Publicado: (2019) -
Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer
por: Wang, Lin, et al.
Publicado: (2020)